Completed PHASE4 INTERVENTIONAL 3-arm NCT01700322

Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study (EST)

Effects of Clopidogrel vs Prasugel vs Ticagrelor on Endothelial Function, Inflammatory and Oxidative Stress Parameters and Platelet Function in Patients Undergoing Coronary Artery Stenting. A Randomised, Prospective Study.

Sponsor: Johannes Gutenberg University Mainz

Conditions Coronary Artery Disease

Interventions Clopidogrel Coronary stenting Prasugrel Ticagrelor

Updated 6 times since 2017 Last updated: Sep 4, 2016 Started: Aug 31, 2012 Primary completion: Jul 31, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Coronary Artery Disease and is currently completed. Johannes Gutenberg University Mainz leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johannes Gutenberg University Mainz

Data source: Johannes Gutenberg University Mainz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mainz, Germany